Urogen Pharma(URGN)
$26.18-0.21 (-0.80%)
URGN
Urogen Pharma hedge funds
$26.18
At close:-0.21 (-0.80%)
Want to see URGN full AI Analyst Report?
Urogen Pharma (URGN) Hedge Fund Trading Activity
676 Followers
Trend: ▲ Hedge Funds Increased Holdings by 296.2K Shares Last Quarter
Hedge Fund Holdings in URGN
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
 Robert L. Bender | Robert Bender&Associates | New | 100.00% | $1,409,902 | 0.29% | ||
 Michael Rockefeller | Woodline Partners LP | Not Changed | 0.00% | $20,344,497 | 0.06% | ||
| Dennis J Purcell | Aisling Capital Management LP | Not Changed | 0.00% | $4,388,040 | 0.93% | ||
| BlackRock, Inc. | Reduced | -2.91% | $126,286,247 | <0.01% | |||
 Cathie Wood | ARK Investment Management LLC | Reduced | -46.56% | $2,204,178 | 0.01% |
FAQ
Which hedge funds hold Urogen Pharma?
The hedge funds that hold the most shares in Urogen Pharma are Dennis J Purcell, BlackRock, Inc. and Michael Rockefeller.
Are hedge funds buying or selling URGN?
In the last quarter hedge funds have Increased their holdings in Urogen Pharma by 296.2K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Urogen Pharma stock?
Warren Buffet currently does not own shares in Urogen Pharma.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
